Cal Pharma, Inc Names Curtis A. Cluff As Chief Executive Officer

Industry Veteran To Drive Strategic Initiatives For Cal Pharma’s Leading Dermal Therapeutic and Aesthetic Brands

Whittier, CA., - September 7, 2016 – Cal Pharma, Inc., a leading developer of advanced therapeutic and aesthetic skin and hair care products, is pleased to announce the appointment of Curtis A. Cluff as its Chief Executive Officer.

Cal Pharma is a technology-centric developer, manufacturer and marketer of eight separate topical brands. Perhaps best known for their popular OTC sun care (under the SPF Rx Brand), OTC pain management (under the Ultracin brand), and hair care products (under the Strong HairPro brands), the company has made significant in-roads in selling through health/lifestyle retailers, country clubs and resorts. Their OTC topical medications and anti-aging have also gained a strong and growing user base through specialty pharmacies, and other physician dispensing. With this appointment, Mr. Cluff will lead the development of focused sales and marketing initiatives in these and other professional channels, as part of building the company’s sales, marketing and distribution capabilities to support it’s accelerating growth.

“I am excited by the wealth of growth opportunities Cal Pharma has with its strong product development and manufacturing resources, and at the same time impressed with what the Cal Pharma team has already accomplished so quickly” Said Mr. Cluff. “This company has developed a diverse set of superior products in treating medical and aesthetic conditions topically, and is poised for dramatic growth as a result.”

Mr. Cluff joins Cal Pharma from Envy Medical, Inc. where he served as the Chief Executive Officer for the last 7 years ,leading the company's successes in raising new capital and driving dramatic domestic and international sales growth by establishing new distribution channels/geographies, developing/launching Envy’s medical products under the Lumixyl® and ClarityMD® brands. during his tenure, Envy has become a medical channel leader with an active sales presence on over 45 countries worldwide. Prior to Envy, Mr. Cluff held top executive roles for Colorescience and Obagi Medical Products. At Obagi, he oversaw the development of the Obagi brand from a small niche medical skincare line when he joined in 2002, to the number one US professional skincare brand by 2005. By the conclusion of his tenure at the end of 2007, Obagi had sales in over 40 countries worldwide and reported over $110 million in sales in its first year as a publicly traded company. Mr. Cluff’s career began as a CPA with the international audit and business advisory firm Deloitte & Touch in 1991, and advanced into executive fancial and operational roles for both publicly and privately traded corporations over the subsequent 11 year and prior to joining Obagi Medical Products.

ABOUT CAL PHARMA — Cal Pharma is a leading therapeutic and cosmetic skincare company. They are setting new standards in multifunctional sun protection with their popular SPF Rx brand, one of eight dynamic skin and hair care brands that the company develops, markets and sells across medical, professional and corporate/government channels. All the products are manufactured in an FDA approved facility under cGMP guidelines. Cal Pharma has over 60 years of combined experience backed by an R&D team of cosmetic chemists, a licensed pharmacist, and a certified dermatologist. All Cal Pharma products are made in the USA.

Cal Pharma is committed to utilizing innovative and functional ingredients to create products that have been formulated in the most effective delivery systems to provide successful results. Areas of expertise include anti aging , acne, sun care, pain formulations and specialty hair care products. More information can be found at http://www.cal-pharma.com, or by calling Cal Pharma offices at (888) 551-7778.